Digital Biomedical Industry Chain and Supply Chain in 
Hainan Free Trade Port

Xiaofeng Liu

doi:10.70711/frim.v3i12.7896

Digital Biomedical Industry Chain and Supply Chain in Hainan Free Trade Port

Xiaofeng Liu

Abstract

The global biopharmaceutical industry has entered a new phase of digital empowerment, where R&D efficiency enhancement and
supply chain resilience are critically dependent on the integration of digital technologies. As a strategic emerging industry, the digital transformation of Hainan Free Trade Port's biomedical industrial chain plays a pivotal role in boosting international competitiveness. This study
focuses on infrastructure development and collaborative mechanisms during the digitalization process of the biopharmaceutical sector, systematically analyzing application scenarios and practical bottlenecks in digital transformation across various industrial chain segments.

Keywords

Hainan Free Trade Port; Biopharmaceuticals; Digital Transformation

Full Text:

PDF

Included Database

References

[1] Wang Tianye. Precision Marketing of Pharmaceutical Brands under the Background of Digital Supply Chain [J]. Business Culture,

2025, (13):140-141.

[2] Ren Jingmei, Zhang Yinghui. Analysis of the Driving Forces and Effects of Digital Transformation of Baiyang Pharmaceutical Supply

Chain [J]. Industrial Innovation Research, 2025, (13):117-119.

[3] Yang Xinyu. The Mechanism and Path of Digital Economy Empowering the Upgrading of Time-honored Brands: An Empirical Analysis

Based on A-share Listed Companies [J]. China Business Review, 2020, 34(14):164-168.

[4] Hu Chan. New Perspectives on Exhibition Economy: An Analysis of Supply Chain Procurement from the Perspective of Pharmaceutical

Exhibitions [J]. China Exhibition, 2025, (15):32-35.

DOI: http://dx.doi.org/10.70711/frim.v3i12.7896

Refbacks

There are currently no refbacks.